Oxford BioMedica

Oxford BioMedica — Acquisitions

Every M&A deal made by Oxford BioMedica, sorted by date.

📍 Oxford Total deals 2 Total value $47.1M View company profile →
2
Total deals
$47.1M
Total value
$23.6M
Avg deal
$30.9M
Largest
Acquisition activity by year
Deals announced per year
07 23
# Acquired Date Type Status Price
1
ABL Europe
ABL Europe specializes in bioproduction, quality control services, and gene ther…
2023-12-04 Acquisition Complete $16.3M Deal →
2
Oxxon Therapeutics
Oxxon Pharmaccines Ltd., an Oxford, UK-based biotech company focused on immunoth…
2007-03-12 Acquisition Complete $30.9M Deal →